Ketryx
PrivateLast Round
Series B
Sep 4, 2025
Total Funding Raised
$55M
Momentum Score
25 /100
Company Overview
Ketryx is a technology company that provides an AI-powered compliance platform for the life sciences industry. Its software is designed to help medical device manufacturers and other regulated companies automate the documentation, traceability, and validation required for regulatory approval from bodies like the FDA and under EU MDR. The platform integrates with existing development tools such as Jira and GitHub to create a self-documenting and self-enforcing software development lifecycle, aiming to significantly reduce documentation time and accelerate product releases. Founded in 2021 by Erez Kaminski, the company serves top medical technology companies and AI-driven healthcare firms. Ketryx has raised over $55 million in funding and has headquarters in Cambridge, Massachusetts, with a presence in Austria.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Compliance, RegTech, Workflow Automation, Quality Management
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ketryx Comps
Public and private peers based on sector, stage, and business model.
Ketryx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 4, 2025 | ||||
| Series A | Dec 5, 2023 | ||||
| Seed | Jul 6, 2022 |
Ketryx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gaingels | Series B |
| Ubiquity Ventures | Series B, Seed, Series A |
| The E14 Fund | Series B |
| 53 Stations | Series B |
| Transformation Capital | Series B |
| Leerink Transformation Partners | Series B |
| Lightspeed Venture Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Powers 25% of the Fortune 500 MedTech market.
- Apr 21, 2026
Platform now touches the lives of 25 million patients.
Ketryx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ketryx's valuation, stock price, and market status.
